Related Experiment Video
Updated: Sep 29, 2025

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Antimicrobial Random Peptide Mixtures Eradicate Acinetobacter baumannii Biofilms and Inhibit Mouse Models of
Hannah E Caraway1, Jonathan Z Lau1, Bar Maron2
1Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Abstract:
Antibiotic resistance is one of the greatest crises in human medicine. Increased incidents of antibiotic resistance are linked to clinical overuse and overreliance on antibiotics. Among the ESKAPE pathogens, Acinetobacter baumannii, especially carbapenem-resistant isolates, has emerged as a significant threat in the context of blood, urinary tract, lung, and wound infections. Therefore, new approaches that limit the emergence of antibiotic resistant A. baumannii are urgently needed. Recently, we have shown that random peptide mixtures (RPMs) are an attractive alternative class of drugs to antibiotics with strong safety and pharmacokinetic profiles. RPMs are antimicrobial peptide mixtures produced by incorporating two amino acids at each coupling step, rendering them extremely diverse but still defined in their overall composition, chain length, and stereochemistry. The extreme diversity of RPMs may prevent bacteria from evolving resistance rapidly. Here, we demonstrated that RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis. Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.
Insights
Random peptide mixtures (RPMs) show promise as a novel therapeutic against antibiotic-resistant Acinetobacter baumannii. These diverse peptide mixtures effectively kill bacteria, prevent biofilm formation, and improve survival in preclinical models.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Antibiotic resistance is a major global health crisis, with carbapenem-resistant Acinetobacter baumannii posing a significant threat.
- The overuse and overreliance on existing antibiotics contribute to the rise of resistant bacterial strains.
- New therapeutic strategies are urgently needed to combat infections caused by antibiotic-resistant pathogens.
Purpose of the Study:
- To evaluate the efficacy of random peptide mixtures (RPMs) as an alternative therapeutic agent against Acinetobacter baumannii.
- To investigate the potential of RPMs to overcome antibiotic resistance and prevent bacterial evolution of resistance.
- To assess the in vivo performance of RPMs in preclinical models of infection.
Main Methods:
- RPMs were synthesized with defined composition, chain length, and stereochemistry, ensuring extreme diversity.
- In vitro assays were performed to assess the bactericidal activity of RPMs against various Acinetobacter baumannii strains and their ability to inhibit and disrupt biofilms.
- In vivo studies utilized mouse models of acute pneumonia, soft tissue infection, and sepsis to evaluate RPMs' therapeutic potential and survival rates.
Main Results:
- RPMs demonstrated rapid and efficient killing of diverse Acinetobacter baumannii strains, including carbapenem-resistant isolates.
- RPMs effectively inhibited the formation of bacterial biofilms and disrupted pre-existing mature biofilms.
- In vivo studies showed that RPMs attenuated bacterial burden in pneumonia and soft tissue infection models and significantly reduced mortality in a sepsis model.
Conclusions:
- Random peptide mixtures represent a promising new class of therapeutics with potential against antibiotic-resistant Acinetobacter baumannii.
- The inherent diversity of RPMs may hinder the rapid evolution of bacterial resistance.
- RPMs exhibit favorable safety and pharmacokinetic profiles, positioning them as a viable alternative to conventional antibiotics.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing

